Literature DB >> 25314358

Telaprevir activity is unaffected by the Q80K polymorphism in hepatitis C virus genotype 1a.

Stephen Shafran.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25314358      PMCID: PMC4205909          DOI: 10.1155/2014/604942

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


× No keyword cloud information.
  4 in total

1.  Response-guided telaprevir combination treatment for hepatitis C virus infection.

Authors:  Kenneth E Sherman; Steven L Flamm; Nezam H Afdhal; David R Nelson; Mark S Sulkowski; Gregory T Everson; Michael W Fried; Michael Adler; Hendrik W Reesink; Marie Martin; Abdul J Sankoh; Nathalie Adda; Robert S Kauffman; Shelley George; Christopher I Wright; Fred Poordad
Journal:  N Engl J Med       Date:  2011-09-15       Impact factor: 91.245

2.  Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.

Authors:  Maria Buti; Kosh Agarwal; Yves Horsmans; William Sievert; Ewa Janczewska; Stefan Zeuzem; Lisa Nyberg; Robert S Brown; Christophe Hézode; Mario Rizzetto; Raymundo Paraná; Sandra De Meyer; Ralph De Masi; Donghan Luo; Kirk Bertelsen; James Witek
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

3.  Susceptibility of treatment-naive hepatitis C virus (HCV) clinical isolates to HCV protease inhibitors.

Authors:  Andrew Bae; Siu-Chi Sun; Xiaoping Qi; Xiaowu Chen; Karin Ku; Angela Worth; Kelly A Wong; Jeanette Harris; Michael D Miller; Hongmei Mo
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

4.  Telaprevir for previously untreated chronic hepatitis C virus infection.

Authors:  Ira M Jacobson; John G McHutchison; Geoffrey Dusheiko; Adrian M Di Bisceglie; K Rajender Reddy; Natalie H Bzowej; Patrick Marcellin; Andrew J Muir; Peter Ferenci; Robert Flisiak; Jacob George; Mario Rizzetto; Daniel Shouval; Ricard Sola; Ruben A Terg; Eric M Yoshida; Nathalie Adda; Leif Bengtsson; Abdul J Sankoh; Tara L Kieffer; Shelley George; Robert S Kauffman; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2011-06-23       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.